Translational Development Acquisition Corp. Ordinary Shares (TDAC) - Total Assets
Based on the latest financial reports, Translational Development Acquisition Corp. Ordinary Shares (TDAC) holds total assets worth $179.98 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See TDAC net asset value for net asset value and shareholders' equity analysis.
Translational Development Acquisition Corp. Ordinary Shares - Total Assets Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares's total assets have evolved over time, based on quarterly financial data.
Translational Development Acquisition Corp. Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
Translational Development Acquisition Corp. Ordinary Shares's total assets of $179.98 Million consist of 0.4% current assets and 99.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $12.57 Trillion | 7182356.2% |
| Goodwill | $9.06 Trillion | 5178082.9% |
Asset Composition Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Translational Development Acquisition Co market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Translational Development Acquisition Corp. Ordinary Shares's current assets represent 0.4% of total assets in 2024, a decrease from 12.4% in 2022.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2024, down from 0.5% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12360438.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is intangible assets at 7182356.2% of total assets.
Translational Development Acquisition Corp. Ordinary Shares Competitors by Total Assets
Key competitors of Translational Development Acquisition Corp. Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ:DMII
|
USA | $504.96 Million |
|
Siddhi Acquisition Corp Class A Common stock
NASDAQ:SDHI
|
USA | $289.04 Million |
|
Plum Acquisition Corp. IV Unit
NASDAQ:PLMKU
|
USA | $180.11 Million |
|
Cohen Circle Acquisition Corp. II Class A Ordinary Shares
NASDAQ:CCII
|
USA | $261.61 Million |
|
Hennessy Capital Investment Corp. VII Unit
NASDAQ:HVIIU
|
USA | $198.28 Million |
|
Sizzle Acquisition Corp. II - Class A ordinary shares
NASDAQ:SZZL
|
USA | $235.83 Million |
|
Bitcoin Infrastructure Acquisition Corp Ltd. Class A Ordinary Shares
NASDAQ:BIXI
|
USA | $225.11K |
|
McKinley Acquisition Corporation Class A Ordinary Shares
NASDAQ:MKLY
|
USA | $176.92 Million |
Translational Development Acquisition Corp. Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.19 | 0.23 | 0.61 |
| Quick Ratio | 0.19 | 0.23 | 0.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-342.26K | $-740.36K | $-40.30K |
Translational Development Acquisition Corp. Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Translational Development Acquisition Corp. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 1.05 |
| Asset Growth Rate (YoY) | 8659008.3% |
| Total Assets | $175.00 Million |
| Market Capitalization | $183.54 Million USD |
Valuation Analysis
Above Book Valuation: The market values Translational Development Acquisition Corp. Ordinary Shares's assets above their book value (1.05x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Translational Development Acquisition Corp. Ordinary Shares's assets grew by 8659008.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
The table below shows the annual total assets of Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $175.00 Million | +8659008.31% |
| 2023-12-31 | $2.02K | -99.54% |
| 2022-12-31 | $437.24K | -- |
About Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.